SWOG S0910: A phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia

British Journal of Haematology

Volumn 165, Issue 4, 2014, Pages 504-509

  Advani, Anjali S ^a   Mcdonough, Shannon ^b   Coutre, Steven ^c   Wood, Brent ^d   Radich, Jerald ^b   Mims, Martha ^e   O'Donnell, Margaret ^f   Elkins, Stephanie ^g   Becker, Michael ^h   Othus, Megan ^b   Appelbaum, Frederick R ^b  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SEATTLE CANCER CARE ALLIANCE   (United States)

^e Baylor Medical Center   (United States)

^f CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^g UNIVERSITY OF MISSISSIPPI   (United States)

^h UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Acute lymphocytic leukaemia; CD22; Epratuzumab; Relapse; Treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CD22 ANTIGEN; CLOFARABINE; CREATININE; CYTARABINE; DIPHENHYDRAMINE; EPRATUZUMAB; METHOTREXATE; PARACETAMOL;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANOREXIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BONE MARROW EXAMINATION; BRAIN DISEASE; BRONCHOSPASM; CANCER CHEMOTHERAPY; CATHETER INFECTION; CELL SURFACE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; CYTOGENETICS; CYTOPLASM; DIARRHEA; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ENTEROCOLITIS; FEBRILE NEUTROPENIA; FEMALE; GINGIVA DISEASE; HEART ARREST; HUMAN; HUMAN CELL; HYPERCALCEMIA; HYPERGLYCEMIA; HYPERKALEMIA; HYPERTENSION; HYPOCALCEMIA; HYPOKALEMIA; HYPONATREMIA; HYPOPHOSPHATEMIA; HYPOTENSION; HYPOXIA; INFECTION; LIVER FAILURE; LUNG INFECTION; MALE; MOUTH PAIN; NEUROLOGIC DISEASE; PHASE 2 CLINICAL TRIAL; PRE B LYMPHOCYTE; PRIORITY JOURNAL; QT PROLONGATION; RELAPSE; RESPIRATORY FAILURE; SEPSIS; TACHYCARDIA; TACHYPNEA; TOOTH INFECTION; TUMOR LYSIS SYNDROME; TUMOR REGRESSION; TYPHLITIS; URTICARIA;

ACUTE LYMPHOCYTIC LEUKAEMIA; CD22; EPRATUZUMAB; RELAPSE; TREATMENT;

ADENINE NUCLEOTIDES; ADULT; AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIGENS, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARABINONUCLEOSIDES; CYTARABINE; DRUG-INDUCED LIVER INJURY; FEBRILE NEUTROPENIA; FEMALE; HEART ARREST; HEMATOLOGIC DISEASES; HUMANS; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECURRENCE; REMISSION INDUCTION; RISK; SALVAGE THERAPY; SIALIC ACID BINDING IG-LIKE LECTIN 2; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84899493381     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12778     Document Type: Article

References (12)

1. Advani, A.S., Gundacker, H.M., Sala-Torra, O., Radich, J.P., Lai, R., Slovak, M.L., Lancet, J.E., Coutre, S., Stuart, R.K., Mims, M.P., Stiff, P.J. & Appelbaum, F.R. (2010) Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia. British Journal of Haematology, 151, 430-434.
2. Boue, D.R. & LeBien, T.W. (1988) Expression and structure of CD22 in acute leukaemia. Blood, 71, 480-486.
3. Fielding, A.K., Richards, S.M., Chopra, R., Lazarus, H.M., Litzow, M.R., Buck, G., Durrant, I.J., Luger, S.M., Marks, D.I., Franklin, I.M., McMillan, A.K., Tallman, M.S., Rowe, J.M. & Goldstone, A.H. (2007) Outcome of 609 adults after relapse of acute lymphoblastic leukaemia (ALL); an MRC UKALL12/ECOG 2993 study. Blood, 109, 944-950.
4. Herrera, L., Farah, R.A. & Pellegrini, V.A. (2000) Immunotoxins against CD19 and CD22 are effective in killing precursor-B acute lymphoblastic leukaemia cells in vitro. Leukaemia, 14, 853-858.
5. Hoelzer, D. (1991) High-dose chemotherapy in adult acute lymphoblastic leukaemia. Seminars in Hematology, 28(3 Suppl 4), 84-89.
6. Hoelzer, D. & Gokbuget, N. (2002) Acute lymphoblastic leukaemia in adults In: Leukaemia, 7th edn. (eds. by E.S. Henderson, T.A. Lister, M.F. Greaves ), pp. 621-656. Saunders, Philadelphia, PA.
7. Kantarjian, H., Thomas, D., Jorgensen, J., Jabbour, E., Kebriaer, P., Rytting, M., York, S., Ravandi, F., Kouari, M., Faderl, S., Rios, M.B., Cortes, J., Fayad, L., Tarnai, R., Wang, S.A., Champlin, R., Advani, A. & Obrien, S. (2012) Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study. The Lancet Oncology, 13, 403-411.
8. Kaplan, E.L. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457-481.
9. Pullarkat, V., Slovak, M.L., Kopecky, K.J., Forman, S.J. & Appelbaum, F.R. (2008) Impact of cytogenetics on the outcome of adult acute lymphoblastic leukaemia: results of the Southwest Oncology Group 9400 Study. Blood, 111, 2563-2572.
10. Raetz, E.A., Cairo, M.S., Borowitz, M.J., Blaney, S.M., Krailo, M.D., Leil, T.A., Reid, J.M., Goldenberg, D.M., Wegner, W.A., Carroll, W.L. & Adamson, P.C. (2008) Chemoimmunotherapy with Epratuzumab in children with acute lymphoblastic leukaemia in marrow relapse: a Children's Oncology Group Pilot Study. Journal of Clinical Oncology, 26, 3756-3762.
11. Raetz, E.A., Cairo, M.S., Borowitz, M.J., Lu, X., Devidas, M., Reid, J.M., Goldenberg, D.M., Wegner, W.A., Whitlock, J.A., Adamson, P.C., Hunger, S.P. & Carroll, W.L. (2011) Reinduction Chemoimmunotherapy with Epratuzumab in relapsed acute lymphoblastic leukaemia (ALL) in Children, Adolescents and Young Adults: Results from Children's Oncology Group (COG) Study ADVL04P2. American Society of Haematology, Abstract 573.
12. Topp, M.S., Goekbuget, N., Zugmaier, G., Viardot, A., Stelljes, M., Neumann, S., Horst, H., Reichie, A., Marks, R., Faul, C., Brueggemann, M., Ritgen, M., Klappers, P., Mergen, N., Goebeler, M.E., Einsele, H. & Bargou, R. (2012) Anti-CD19 BiTE Blinatumomab induces high complete remission rates and prolongs overall survival in adult patients with relapsed/refractory precursor B-precursor acute lymphoblastic leukemia. Blood (ASH Annual Meeting Abstracts), 120, 670.